CN Stock MarketDetailed Quotes

688443 Chongqing Genrix Biopharmaceutical

Watchlist
  • 22.75
  • -0.10-0.44%
Market Closed Sep 13 15:00 CST
8.34BMarket Cap-10761P/E (TTM)

Chongqing Genrix Biopharmaceutical Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Chongqing Genrix Biopharmaceutical Q2 2024 Earnings Date

Currency：CNYAug 31, 2024

Estimate
(YoY)		 Actual
(YoY)		 Vs Estimate
(% Chg)
Revenue
--
6.33K
--
-80.69%
Net Income
--
-198.16M
--
-5.86%
Analyst Rating
Strong Buy

Sep 13, 2024

Chongqing Genrix Biopharmaceutical Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 3 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: CNY

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2025/FY-- / 271.667M--
--2024/FY-- / 67.333M--
--2023/FY1.212M / 50.000K--
DatePeriodRevenue/EstimateEarnings Call
--2025/FY-- / 271.667M--
--2024/FY-- / 67.333M--
--2023/FY1.212M / 50.000K--
--------
--------

Unlock Free Earnings Estimates

Chongqing Genrix Biopharmaceutical Earnings Reports

  • 2024 Semi-Annual Report

    Aug 30 12:00 ET

  • 2024 Semi-Annual Report Summary

    Aug 30 12:00 ET

  • 2024 First Quarter Report

    Apr 29 12:00 ET

  • 2023 Annual Report Summary

    Apr 29 12:00 ET

    • Read more

    Analysis

    Analyst Rating

    Updated: Sep 13, 2024

    Strong Buy

    • Strong Buy

      80.00%

    • Buy

      20.00%

    • Hold

      0.00%

    • Underperform

      0.00%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    CN
    Overall
    Symbol
    Latest Price
    % Chg

    No Data